rs199828189
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_001365276.2(TNXB):c.9440-12_9440-10delTCT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00484 in 1,607,978 control chromosomes in the GnomAD database, including 160 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0055 ( 22 hom., cov: 32)
Exomes 𝑓: 0.0048 ( 138 hom. )
Consequence
TNXB
NM_001365276.2 intron
NM_001365276.2 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.249
Publications
1 publications found
Genes affected
TNXB (HGNC:11976): (tenascin XB) This gene encodes a member of the tenascin family of extracellular matrix glycoproteins. The tenascins have anti-adhesive effects, as opposed to fibronectin which is adhesive. This protein is thought to function in matrix maturation during wound healing, and its deficiency has been associated with the connective tissue disorder Ehlers-Danlos syndrome. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. It is one of four genes in this cluster which have been duplicated. The duplicated copy of this gene is incomplete and is a pseudogene which is transcribed but does not encode a protein. The structure of this gene is unusual in that it overlaps the CREBL1 and CYP21A2 genes at its 5' and 3' ends, respectively. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
TNXB Gene-Disease associations (from GenCC):
- Ehlers-Danlos syndromeInheritance: AR Classification: DEFINITIVE Submitted by: G2P
- Ehlers-Danlos syndrome due to tenascin-X deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Illumina, PanelApp Australia, Orphanet
- familial vesicoureteral refluxInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- vesicoureteral reflux 8Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 6-32049596-GAGA-G is Benign according to our data. Variant chr6-32049596-GAGA-G is described in ClinVar as Benign. ClinVar VariationId is 261176.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00554 (843/152252) while in subpopulation AMR AF = 0.031 (474/15304). AF 95% confidence interval is 0.0287. There are 22 homozygotes in GnomAd4. There are 480 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 22 AR,AD gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TNXB | NM_001365276.2 | c.9440-12_9440-10delTCT | intron_variant | Intron 27 of 43 | ENST00000644971.2 | NP_001352205.1 | ||
| TNXB | NM_001428335.1 | c.10181-12_10181-10delTCT | intron_variant | Intron 28 of 44 | NP_001415264.1 | |||
| TNXB | NM_019105.8 | c.9434-12_9434-10delTCT | intron_variant | Intron 27 of 43 | NP_061978.6 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TNXB | ENST00000644971.2 | c.9440-12_9440-10delTCT | intron_variant | Intron 27 of 43 | NM_001365276.2 | ENSP00000496448.1 | ||||
| TNXB | ENST00000647633.1 | c.10181-12_10181-10delTCT | intron_variant | Intron 28 of 44 | ENSP00000497649.1 | |||||
| TNXB | ENST00000375244.7 | c.9440-12_9440-10delTCT | intron_variant | Intron 27 of 43 | 5 | ENSP00000364393.3 |
Frequencies
GnomAD3 genomes AF: 0.00550 AC: 837AN: 152134Hom.: 21 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
837
AN:
152134
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0103 AC: 2483AN: 241676 AF XY: 0.00785 show subpopulations
GnomAD2 exomes
AF:
AC:
2483
AN:
241676
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00476 AC: 6936AN: 1455726Hom.: 138 AF XY: 0.00436 AC XY: 3152AN XY: 723404 show subpopulations
GnomAD4 exome
AF:
AC:
6936
AN:
1455726
Hom.:
AF XY:
AC XY:
3152
AN XY:
723404
show subpopulations
African (AFR)
AF:
AC:
16
AN:
33300
American (AMR)
AF:
AC:
2020
AN:
44542
Ashkenazi Jewish (ASJ)
AF:
AC:
2
AN:
26006
East Asian (EAS)
AF:
AC:
1634
AN:
39568
South Asian (SAS)
AF:
AC:
28
AN:
86132
European-Finnish (FIN)
AF:
AC:
396
AN:
52064
Middle Eastern (MID)
AF:
AC:
0
AN:
5420
European-Non Finnish (NFE)
AF:
AC:
2670
AN:
1108640
Other (OTH)
AF:
AC:
170
AN:
60054
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
404
809
1213
1618
2022
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
136
272
408
544
680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00554 AC: 843AN: 152252Hom.: 22 Cov.: 32 AF XY: 0.00645 AC XY: 480AN XY: 74442 show subpopulations
GnomAD4 genome
AF:
AC:
843
AN:
152252
Hom.:
Cov.:
32
AF XY:
AC XY:
480
AN XY:
74442
show subpopulations
African (AFR)
AF:
AC:
14
AN:
41552
American (AMR)
AF:
AC:
474
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
108
AN:
5174
South Asian (SAS)
AF:
AC:
2
AN:
4822
European-Finnish (FIN)
AF:
AC:
70
AN:
10620
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
167
AN:
67994
Other (OTH)
AF:
AC:
8
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
36
72
107
143
179
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
33
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Ehlers-Danlos syndrome Benign:1
Jul 22, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Jul 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AG_spliceai
Position offset: 39
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.